タンパク質工学の世界市場規模、シェア、成長分析：製品別、技術別、タンパク質タイプ別、エンドユーザー別 - 産業予測（2024～2031年）

世界のタンパク質工学の市場規模は、2022年に21億6,000万米ドルとなり、予測期間中（2024～2031年）のCAGRは16.60%で、2023年の25億2,000万米ドルから、2031年までには86億米ドルに成長する見通しです。

バイオテクノロジーや製薬業界は、費用対効果や患者の転帰の面で非タンパク質医薬品より優れているとして、タンパク質ベースの治療法の進歩にますます重点を置くようになっています。このシフトは、特にがんや自己免疫疾患などの病態に対処するための標的治療に対する需要の高まりによって促進され、タンパク質工学技術の採用を後押ししています。COVID-19パンデミックは、特にワクチンや診断薬の開発において、タンパク質工学が極めて重要な役割を果たすなど、この動向をさらに促進しました。例えば、2021年7月、ドイツのアイントホーフェン工科大学の科学者は、コロナウイルス抗体を検出する生物発光診断キットを考案し、このような技術革新の実用化を強調しました。COVID-19とそれ以降に対するタンパク質ベースの治療法を模索する臨床試験が増加し、政府の支援や資金援助も増えていることから、タンパク質工学市場は大きく拡大する態勢にあります。Generate BiomedicinesとAmgenとの提携のような業界関係者間の協力関係や、特に十分なサービスを受けていない地域における慢性疾患や栄養不良への対応におけるタンパク質工学ソリューションに対する認識とニーズの高まりは、この分野の成長の可能性をさらに裏付けています。合成生物学や個別化治療のような分野を含め、継続的な投資と進歩により、タンパク質工学業界の見通しは当面明るいと思われます。

目次

エグゼクティブサマリー

• 市場概要
• 運命の輪

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主な市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主な投資の分析
• 主な成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

タンパク質工学の世界市場：製品別

• 市場概要
• 機器
• 試薬
• ソフトウェア・サービス

タンパク質工学の世界市場：技術別

• 市場概要
• 合理的なタンパク質設計
• 指向性進化
• ハイブリッドアプローチ
• De Novoタンパク質設計
• その他

タンパク質工学の世界市場：タンパク質タイプ別

• 市場概要
• インスリン
• モノクローナル抗体
• ワクチン
• 成長因子
• コロニー刺激因子
• 凝固因子
• インターフェロン
• その他

タンパク質工学の世界市場：エンドユーザー別

• 市場概要
• 学術研究機関
• 受託調査機関
• 製薬・バイオテクノロジー企業

タンパク質工学の世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2021年）
• 主な市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2021年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Genscript Biotech Corporation
• Codexis, Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• PerkinElmer, Inc.
• Creative Biomart
• Abcam plc
• Enzyme by Design Ltd.
• Twist Bioscience Corporation
• GenScript Biotech Corporation
• Cyrus Biotechnology, Inc.
• Integrated DNA Technologies, Inc.（IDT）
• New England Biolabs
• Genentech, Inc.
• Promega Corporation
• Sutro Biopharma, Inc.

Global Protein Engineering Market size was valued at USD 2.16 Billion in 2022 and is poised to grow from USD 2.52 Billion in 2023 to USD 8.6 Billion by 2031, at a CAGR of 16.60% during the forecast period (2024-2031).

Biotechnology and pharmaceutical sectors are increasingly directing their focus towards the advancement of protein-based therapies, citing their superiority over non-protein drugs in terms of cost-effectiveness and patient outcomes. This shift is particularly fueled by a rising demand for targeted treatments to combat conditions such as cancer and autoimmune diseases, propelling the adoption of protein engineering techniques. The COVID-19 pandemic has further catalyzed this trend, notably in the development of vaccines and diagnostics, where protein engineering has played a pivotal role. For instance, in July 2021, scientists at Eindhoven University of Technology in Germany devised a bioluminescent diagnostic kit to detect coronavirus antibodies, highlighting the practical applications of such innovations. With an uptick in clinical trials exploring protein-based treatments for COVID-19 and beyond, coupled with increased governmental support and funding, the protein engineering market is poised for significant expansion. Collaborations between industry players, such as the partnership between Generate Biomedicines and Amgen, and the growing awareness and need for protein engineering solutions in addressing chronic diseases and malnutrition, particularly in underserved regions, further underscore the sector's potential for growth. With ongoing investments and advancements, including in areas like synthetic biology and personalized therapy, the outlook for the protein engineering industry appears promising for the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Engineering Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Protein Engineering Market Segmental Analysis

The global protein engineering market is segmented based on technology, protein type, product, end user, and region. In terms of product, the market is segmented into instruments, reagents, and software & services. With respect to segmentation by technology, the market is widespread into rational protein design, directed evolution, hybrid approach, de novo protein design, and others. Based on protein type, the market is grouped into insulin, monoclonal antibodies, vaccines, growth factors, colony stimulating factors, coagulation factors, interferon, and others. By end-use, the market is segmented into academic research institutes, contract research organizations, and pharmaceutical & biotechnology companies. Region wise, the market is widespread into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Protein Engineering Market

Protein engineering is pivotal in advancing therapeutic proteins like antibodies, enzymes, and hormones, vital in combating chronic illnesses and meeting the escalating demand for precise and tailored treatments. The surge in chronic diseases and the call for personalized therapies underscore the necessity for innovative and enhanced therapeutic proteins.

Restraints in the Global Protein Engineering Market

Protein engineering necessitates substantial investment in research and development endeavors, encompassing procurement of laboratory equipment, specialized skill sets, and undertaking clinical trials. The considerable expenses tied to these pursuits can pose a significant barrier, particularly for small to medium-sized enterprises.

Market Trends of the Global Protein Engineering Market

The increasing desire for personalized medicine involves tailoring treatments to individual patients according to their genetic composition. Through protein engineering, there's a capacity to craft personalized therapeutic proteins and antibodies, precisely targeting particular ailments and enhancing patient prognoses.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Protein Engineering Market by Product

• Market Overview
• Instruments
• Reagents
• and Software & Services

Global Protein Engineering Market by Technology

• Market Overview
• Rational Protein Design
• Directed Evolution
• Hybrid Approach
• De Novo Protein Design
• and Others

Global Protein Engineering Market by Protein Type

• Market Overview
• Insulin
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Colony Stimulating Factors
• Coagulation Factors
• Interferon
• and Others

Global Protein Engineering Market by End-User

• Market Overview
• Academic Research Institutes
• Contract Research Organizations
• and Pharmaceutical & Biotechnology Companies

Global Protein Engineering Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biomart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzyme by Design Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyrus Biotechnology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sutro Biopharma, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments